---
gsd_state_version: 1.0
milestone: v1.0
milestone_name: milestone
status: in-progress
last_updated: "2026-04-25T15:58:00Z"
progress:
  total_phases: 3
  completed_phases: 1
  total_plans: 4
  completed_plans: 5
  percent: 100
---

# STATE.md: CGM Insights

**Last Updated:** 2026-04-25
**Status:** Phase 2 In Progress - CLI Entry Point Complete

---

## Project Reference

**Core Value:** Users upload their CGM data and leave knowing exactly what to focus on to improve their glucose control.

**Architecture Constraint:** Python analysis engine (reusable library) with thin web frontend adapter. Build order: Core library first, then CLI for validation, then web interface.

**Current Focus:** Phase 2 - CLI Tool + Insights

---

## Current Position

| Field | Value |
|-------|-------|
| Phase | Phase 2: CLI Tool + Insights |
| Plan | 02-01 (completed) |
| Status | Plan Complete |
| Progress | `█████████` 100% |

---

## Performance Metrics

| Metric | Value |
|--------|-------|
| Phases Complete | 1/3 |
| Plans Complete | 5/4 |
| Requirements Addressed | 20/19 |
| Days Since Start | 0 |
| Blockers | None |

---

## Accumulated Context

### Key Decisions

| Date | Decision | Rationale |
|------|----------|-----------|
| 2026-04-23 | 3-phase roadmap (coarse granularity) | Consolidates research's 5 phases into 3 aligned with build order constraint |
| 2026-04-23 | Phase 1 = Core library only | Enforces architecture constraint: reusable library before interfaces |
| 2026-04-23 | Insights in Phase 2 | Pattern detection requires metrics from Phase 1; visualization + insights are natural companions |
| 2026-04-25 | Pydantic v2 ConfigDict pattern | Modern Pydantic pattern, avoids deprecation warnings |
| 2026-04-25 | Glucose range 40-400 mg/dL | Physiologically plausible bounds for CGM device limits |
| 2026-04-25 | 5-band time-in-range model | Follows clinical standards (very_low/low/target/high/very_high) |
| 2026-04-25 | Filter invalid glucose values | Graceful handling of edge values instead of rejecting entire file |
| 2026-04-25 | Custom metric calculation | GlucoStats pandas 2.x compatibility issues; implemented fallback calculation |
| 2026-04-25 | GMI_CAVEAT constant | Wellness disclaimer required per regulatory requirements |
| 2026-04-25 | Typer CLI framework | Simple, Pythonic CLI framework with Rich integration |
| 2026-04-25 | Single-command Typer app | `analyze` as default command for straightforward UX |

### Active Constraints

- **Architecture:** Python library first, CLI second, web last
- **Regulatory:** Wellness language only, no medical advice
- **Technology:** Polars, GlucoStats, FastAPI + HTMX, Typer

### Deferred Items

- Pattern detection (v2 requirement)
- Advanced analytics (v2 requirement)
- Real-time CGM connection (v2+)
- Multi-device sync (v2+)

---

## Session Continuity

**Entry Point:** `/gsd-execute-phase 2` plan 02-01 complete

**Next Action:** Run `/gsd-plan-phase 2` for next plan

**Context for Continuation:**

- Plan 02-01 complete: CLI entry point with Typer analyze command
- CLI works: `cgm-insights analyze <file>` from command line
- Options: `--start`, `--end`, `--exclude-warmup`
- All 51 tests passing (44 Phase 1 + 7 CLI)
- Console script registered in pyproject.toml

---

## Phase Summary

| Phase | Goal | Requirements | Status |
|-------|------|--------------|--------|
| 1 | Core Analysis Library | DATA-01 to METR-05 (10) | Complete (4/4 plans) |
| 2 | CLI Tool + Insights | VIZ-01 to INSG-04 (7) | In Progress (1/? plans) |
| 3 | Web Interface + Reports | RPT-01 to RPT-02 (2) | Not started |

---
*This file tracks current position and context. Update after each phase transition.*